Interactions between medicines in an office of community drugstore

Authors

  • C Ribes Moya Farmacéutica Comunitaria

Keywords:

Interacción, fármacos, farmacia, farmacodinámico, farmacocinético, PRM

Abstract

Objective: To quantify, to value and to analyze the pharmacological interactions in the patients who come to a community pharmacy.

Method: Cross-sectional study of one year in a community pharmacy of Valencia. The interactions were detected by the program BotPlus of the General Council of Pharmacists’ Official Colleges.

Results: 63,64 % of the interactions took place in women. More than 63 % appeared in major of 56 years. 57,94 % were pharmacodinamic type. 69,16 % were important or potentially important. 57,01 % were concerning the safety. In 69,16 % a clinical control of the patient was recommended. The interaction of anti-inflammatories-non-steroidal and diuretics it was the one that appeared with a major frequency.

Conclusions: It is necessary to establish an action plan with standard operating protocols to possible interactions and interventions in the education of patients to minimize the occurrence of drug-related problems.

Downloads

Download data is not yet available.

References

Factores que modifican la respuesta farmacológica. Sección 22. Capitulo 301. Manual Merck. 17ª edición. [edición electrónica]. Disponible en: <http://www.msd.com.mx/assets/hcp/biblioteca/manual_merck/content_mmerck/MM_22_301.htm>

Rodríguez Ledo P, Modrego Navarro A. Proyectos actuales, innovación en investigación, nuevos proyectos, y proyectos autonómicos. Medicina General. 2008; 107: 354-355.

Rollason V, Vogt N. Reduction of polypharmacy in the elderly. A systematic review of the role of the pharmacist. Drugs and Aging. 2003; 20: 817-832.

Tamblyn RM, McLeod PJ, Abrahamowicz A, Laprise R. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. CMAJ 1996; 154: 1177–84.

Seymur R, Routledge P. Important drug-drug interactions in the elderly. Drugs and Aging. 1998;12:485-94.

Juurlink D, Mamdani M, Kopp A, Laupacis A, Redelmeier D. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003; 289:1652-8.

Grupo de investigación en Atención farmacéutica de la Universidad de Granada, Grupo de investigación en Farmacología de la Universidad de Granada, Fundación Pharmaceutical Care de España y SEFaC. Tercer Consenso de Granada sobre Problemas Relacionados con Medicamentos (PRM) y Resultados Negativos asociadosa la Medicación (RNM). Ars Pharmaceutica. 2007; 48 (1): 5-17.

Grupo de investigación en Atención farmacéutica de la Universidad de Granada, Grupo de investigación en Farmacología de la Universidad de Granada, Grupo de investigación en Farmacología Aplicada y Farmacoterapia de la Universidad de Sevilla. Segundo Consenso de Granada sobre Problemas Relacionados con Medicamentos. Ars Pharmaceutica. 2002; 43 (3-4): 175-184

Ibáñez A, Alcalá M, García J y Puche E. Interacciones medicamentosas en pacientes de un servicio de medicina interna. Farmacia Hospitalaria. 2008; 32(5):293-297.

Galetta DD, Calderón de Cabrera L, Durán MG, Núñez TJ. Detección de interacciones medicamentosas, en pacientes ingresados a la unidad de cuidados intensivos del Instituto Autónomo Hospital Universitario de los Andes (Serie Clínica). VITAE Academia Biomédica Digital [edición electrónica]. 2005; 25. [citado 24 Noviembre 2009] Disponible en: <http://vitae.ucv.ve/?module=articulo&rv=11&n=132> .

Lima REF, Cassiani SHB. Interacciones medicamentosas potenciales en pacientes de una unidad de terapia intensiva de un hospital universitario. Revista Latino-am Enfermagem. 2009; 17(2). Disponible en: <http://www.scielo.br/pdf/rlae/v17n2/es_13.pdf>

Oliver B, Moranta F. Proyecto ICOF. Interconsulta on-line farmacológica. Estudio para la detección y evaluación de interacciones farmacológicas. Pharmaceutical Care. 2007; 9 (Suplemento Congreso): 21-22.

Downloads

Published

2011-03-20

How to Cite

1.
Ribes Moya C. Interactions between medicines in an office of community drugstore. Ars Pharm [Internet]. 2011 Mar. 20 [cited 2024 Jul. 22];52(1):16-22. Available from: https://revistaseug.ugr.es/index.php/ars/article/view/4698

Issue

Vol. 52 No. 1 (2011)

Section

Original Articles

License

The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:

  1. The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.

b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.

c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).